However, within a controlled postmarketing discontinuation review of panic dysfunction clients who gained alprazolam, the duration of procedure (3 months when compared with 6 months) had no effect on the flexibility of patients to taper to zero dose.g., continuing drug use In spite of damaging repercussions, giving a higher priority to drug use tha